Another more recent study demonstrated high levels of TREM2+ TAMs predicted worse overall survival in both lung adenocarcinoma and lung squamous cell carcinoma, which is also in disagreement with the pan-cancer analysis. The gene discussed is TREM2; the disease is squamous cell lung carcinoma.